StonvexLoading…
StonvexStonvexStonvexCore line items from THR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $498.21M | $494.63M | $440.59M | $355.67M |
Operating Income | $79.76M | $75.37M | $55.19M | $38.41M |
Net Income | $53.52M | $51.59M | $33.67M | $20.09M |
EPS (Diluted) | $1.57 | $1.51 | $1.00 | $0.60 |
Total Assets | $755.45M | $767.74M | $649.63M | $636.67M |
Total Liabilities | $260.14M | $292.85M | $230.64M | $237.47M |
Cash & Equivalents | $39.54M | $48.63M | $35.63M | $41.45M |
Free Cash Flow OCF − CapEx | $52.87M | $54.94M | $48.26M | $23.53M |
Shares Outstanding | 33.24M | 33.72M | 33.51M | 33.36M |